Ensysce Biosciences Stock Forecast
NASDAQ: ENSCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.5199 -1.35%
ENSC analyst consensus
Consensus
none
Avg. price target
$8.25+1465.46%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $8.25, with a high estimate of $8.25 and a low estimate of $8.25. The average target implies upside of 1465.5% from the current price of $0.527. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ENSC.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $8.25 | +1465.46% |
| Average target | $8.25 | +1465.46% |
| High target | $8.25 | +1465.46% |